Evidence map›Paper›PMID 29236683›Full record

ArticleNature2017

Effector CD8 T cells dedifferentiate into long-lived memory cells.

Ben Youngblood, J Scott Hale, Haydn T Kissick, Eunseon Ahn, Xiaojin Xu, Andreas Wieland, Koichi Araki, Erin E West, Hazem E Ghoneim, Yiping Fan and 6 more

Abstract read
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 307 papers.

0numbers the graph read from it
0cells of the map it votes in
307citing papers in PubMed
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

307 citing papers in PubMed, 478 citations in OpenAlex.

  1. Trial
  2. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Review
  4. CD8Cell reports. Medicine · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. CD8Science China. Life sciences · 2026
    Review
  9. Design principles of the cytotoxic CD8Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Review
  11. Article
  12. Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification.International journal of molecular sciences · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Oncoimmunology · 2025
    Article

247 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Ben YoungbloodEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
J Scott HaleEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Haydn T KissickDepartment of Urology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Eunseon AhnEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Xiaojin XuEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Andreas WielandEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Koichi ArakiEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Erin E WestEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Hazem E GhoneimDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Yiping FanDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Pranay DograDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Carl W DavisEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Bogumila T KoniecznyEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Rustom AntiaDepartment of Biology, Emory University, Atlanta, Georgia 30322, USA.
Xiaodong ChengDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Rafi AhmedEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Emory University · USSt. Jude Children's Research Hospital · US

Funding

VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGEDU19AI057266 · NIAID · EMORY UNIVERSITY · PI Rafi Ahmed · 2003 to 2026
$81.7M
Targeting the PD-1 signaling pathway to rescue HIV T cell dysfunctionP01AI080192 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI · 2008 to 2012
$12.6M
Modeling the dynamics and evolution of immune responses to influenza virusesU19AI117891 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2015 to 2019
$8.4M
T CELL MEMORY TO VIRUSESR01AI030048 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AHMED, RAFI · 1990 to 2022
$5.2M
T CELL MEMORY TO VIRUSESR37AI030048 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI · 2001 to 2010
$3.9M
Translational Regulation of CD8 T-Cell Immunity - Transfer of R01AI139675 from EmoryR01AI139675 · NIAID · EMORY UNIVERSITY · PI ARAKI, KOICHI · 2018 to 2022
$2.3M
Epigenetic Regulation of T-cell Exhaustion During Treated Chronic HIV InfectionR01AI114442 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI YOUNGBLOOD, BENJAMIN ALAN · 2015 to 2019
$2.1M
NIAID NIH HHS N01 AI030048NIAID NIH HHS P01 AI080192NIAID NIH HHS R01 AI030048NIAID NIH HHS R01 AI114442NIAID NIH HHS R01 AI139675NIAID NIH HHS U19 AI057266NIAID NIH HHS U19 AI117891
6 · The paper itself

Abstract

Memory CD8 T cells that circulate in the blood and are present in lymphoid organs are an essential component of long-lived T cell immunity. These memory CD8 T cells remain poised to rapidly elaborate effector functions upon re-exposure to pathogens, but also have many properties in common with naive cells, including pluripotency and the ability to migrate to the lymph nodes and spleen. Thus, memory cells embody features of both naive and effector cells, fuelling a long-standing debate centred on whether memory T cells develop from effector cells or directly from naive cells. Here we show that long-lived memory CD8 T cells are derived from a subset of effector T cells through a process of dedifferentiation. To assess the developmental origin of memory CD8 T cells, we investigated changes in DNA methylation programming at naive and effector cell-associated genes in virus-specific CD8 T cells during acute lymphocytic choriomeningitis virus infection in mice. Methylation profiling of terminal effector versus memory-precursor CD8 T cell subsets showed that, rather than retaining a naive epigenetic state, the subset of cells that gives rise to memory cells acquired de novo DNA methylation programs at naive-associated genes and became demethylated at the loci of classically defined effector molecules. Conditional deletion of the de novo methyltransferase Dnmt3a at an early stage of effector differentiation resulted in reduced methylation and faster re-expression of naive-associated genes, thereby accelerating the development of memory cells. Longitudinal phenotypic and epigenetic characterization of the memory-precursor effector subset of virus-specific CD8 T cells transferred into antigen-free mice revealed that differentiation to memory cells was coupled to erasure of de novo methylation programs and re-expression of naive-associated genes. Thus, epigenetic repression of naive-associated genes in effector CD8 T cells can be reversed in cells that develop into long-lived memory CD8 T cells while key effector genes remain demethylated, demonstrating that memory T cells arise from a subset of fate-permissive effector T cells.

Indexed as

Cell DedifferentiationImmunologic MemoryAnimalsCD8-Positive T-LymphocytesDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDNA Methyltransferase 3AEpigenesis, GeneticFemaleLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMaleMiceMice, Inbred C57BLDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADnmt3a protein, mouse

Identifiers

PMID29236683
PMCPMC5965677
OpenAlexW2774214122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.